share_log

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4:持股变动声明-高管 Glover Stephen C.
美股SEC公告 ·  2024/07/19 09:36

牛牛AI助手已提取核心信息

Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
2023年5月24日,ZyVersa Therapeutics, Inc.(ZVSA)的首席执行官Stephen C. Glover参与了一项股票交易。然而,在公告中并未披露交易的具体细节,包括交易的股票数量、股票性质、交易价格以及交易总价值。因此,Glover在交易后持有的股票数量仍未知。
2023年5月24日,ZyVersa Therapeutics, Inc.(ZVSA)的首席执行官Stephen C. Glover参与了一项股票交易。然而,在公告中并未披露交易的具体细节,包括交易的股票数量、股票性质、交易价格以及交易总价值。因此,Glover在交易后持有的股票数量仍未知。

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。